Poly(ADP-ribose) polymerase is a regulator of chemokine production: Relevance for the pathogenesis of shock and inflammation

Molecular Medicine

Volumn 8, Issue 5, 2002, Pages 283-289

  Haskó, György ^a   Mabley, Jon G ^a   Németh, Zoltán H ^a   Pacher, Pál ^a   Deitch, Edwin A ^a   Szabó, Csaba ^a  

^a INOTEK CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CELL CULTURE; COLITIS; CYTOKINE PRODUCTION; DISEASE MODEL; ENZYME INHIBITION; FIBROBLAST CULTURE; GENE DELETION; IMMUNOSTIMULATION; IN VIVO STUDY; MACROPHAGE ACTIVATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEPTIC SHOCK;

ANIMALS; CHEMOKINES; COLITIS; FIBROBLASTS; INFLAMMATION; MACROPHAGES; MICE; POLY(ADP-RIBOSE) POLYMERASES; SHOCK;

EID: 0036391974     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. De Murcia G, Shall S. (eds) (2000) From DNA Damage and Stress Signaling to Cell Death: Poly ADP-Ribosylation Reactions. Oxford: Oxford University Press.
2. Szabo C. (ed) (2000) Cell Death: The role of PARP. Boca Raton, FL: CRC Press.
3. Smith S. (2001) The world according to PARP. Trends Biochem. Sci. 26: 174-179.
4. Szabó C, Zingarelli B, O'Connor M, Salzman AL. (1996) DNA strand breakage, activation of poly-ADP ribosyl synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. U.S.A. 93: 1753-1758.
5. Virág L, Scott GS, Marmer D, Cuzzocrea S, Salzman AL, Szabó C. (1998) Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology 94: 345-355.
6. Ha HC, Snyder SH. (1999) Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. U.S.A. 96: 13978-13982.
7. Zhang J, Dawson VL, Dawson TM, Snyder SH. (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687-689.
8. Eliasson MJ, Sampei K, Mandir AS, et al. (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3: 1089-1095.
9. Zingarelli B, Salzman AL, Szabo C. (1998) Genetic disruption of poly (ADP ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia-reperfusion injury. Circ. Res. 83: 85-94.
10. Szabo C, Dawson VL. (1998) Role of poly (ADP-ribose) synthetase activation in inflammation and reperfusion injury. Trends Pharmacol. Sci. 19: 287-298.
11. Szabó C, Lim LH, Cuzzocrea S, et al. (1997) Inhibition of poly (ADP-ribose) synthetase exerts anti-inflammatory effects and inhibits neutrophil recruitment. J. Exp. Med. 186: 1041-1049.
12. Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, Szabó C. (1998) Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation. Eur. J. Pharm. 342: 67-76.
13. Zingarelli B, Szabo C, Salzman AL. (1999) Blockade of Poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis. Gastroenterology 116: 335-345.
14. Szabó C, Virág L, Cuzzocrea S, et al. (1998) Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthetase. Proc. Natl. Acad. Sci. U.S.A. 95: 3867-3872.
15. Mackay CR. (2001) Chemokines: immunology's high impact factors. Nat. Immunol. 2: 95-101.
16. Haskó G, Kuhel DG, Chen JF, et al. (1999) Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14: 2065-2074.
17. Takeshita S, Takeshita F, Haddad DE, Ishii KJ, Klinman DM. (2000) CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression. Cell. Immunol. 206: 101-106.
18. Németh ZH, Mabley JG, Deitch EA, Szabó C, Haskó G. (2001) Inhibition of the Na(+)/H(+) antiporter suppresses IL-12 p40 production by mouse macrophages. Biochem. Biophys. Acta 1539: 233-242.
19. Haskó G, Szabó C, Németh ZH, Deitch EA. (2001) Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression. Immunology 103: 473-478.
20. Gilad E, Wong HR, Zingarelli B, et al. (1998) Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation. FASEB J. 12: 685-693.
21. Szabo C, Wong H, Bauer P, et al. (1997) Regulation of components of the inflammatory response by 5-iodo-6-amino-1,2-benzopyrone, and inhibitor of poly (ADP-ribose) synthetase and pleiotropic modifier of cellular signal pathways. Int. J. Oncol. 10: 1093-1101.
22. Wang ZQ, Auer B, Stingl L, et al. (1995) Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 9: 509-520.
23. Rath HC, Schultz M, Freitag R, et al. (2001) Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 69: 2277-2285.
24. Liaudet L, Soriano FG, Szabo E, et al. (2000) Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose)polymerase. Proc. Natl. Acad. Sci. U.S.A. 97: 10203-10208.
25. Soriano FG, Virag L, Jagtap P, et al. (2001) Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nat. Med. 7: 108-113.
26. Perkins E, Sun D, Nguyen A, et al. (2001) Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Cancer Res. 61: 4175-4183.
27. Oliver FJ, Menissier-de Murcia J, Nacci C, et al. (1999) Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 18: 4446-4454.
28. Hassa PO, Hottiger MO. (1999) A role of poly (ADP-ribose) polymerase in NF-kappaB transcriptional activation. Biol. Chem. 380: 953-958.
29. Hassa PO, Covic M, Hasan S, Imhof R, Hottiger MO. (2001) The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J. Biol. Chem. 276: 45588-45597.
30. Chang WJ, Alvarez-Gonzalez R. (2001) The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1. J. Biol. Chem. 276: 47664-47670.
31. Ha HC, Hester LD, Snyder SH. (2002) Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc. Natl. Acad. Sci. U.S.A. 99: 3270-3275.
32. Murphy PM. (2001) Chemokines and the molecular basis of cancer metastasis. N. Engl. J. Med. 345: 833-835.
33. Horuk R. (2001) Chemokine receptors. Cytokine Growth Factor Rev. 12: 313-335.
34. Blease K, Lukacs NW, Hogaboam CM, Kunkel SL. (2000) Chemokines and their role in airway hyper-reactivity. Respir. Res. 1: 54-61.